mayo clinic glp 1 drops Primary Care in Rochester and Kasson GLP-1RA and thyroid cancer: New

Semaglutide (Single Receptor) Ozempic FDA-approved for type 2 diabetes Wegovy higher-dose version, FDA-approved for obesity Semaglutide activates one receptor: GLP-1

PMC 11890917

Clinical trials demonstrated significant weight reduction when combined with lifestyle interventions

Research published last year in The BMJ found that '[GLP-1 drug use] was not associated with a substantially increased risk of thyroid cancer'

The following counseling tips can help dietitians, and all clinicians, improve short- and long-term use of these weight management medications

Accurate tracking of your dose, timing, side effects, weight, and dietary patterns creates a personal dataset that makes optimizing your protocol dramatically easier